Magnetic Resonance-based fibrosis markers in patients with Non-Alcoholic Fatty Liver Disease: Exploratory data from the Turin cohort. (March 2023)
- Record Type:
- Journal Article
- Title:
- Magnetic Resonance-based fibrosis markers in patients with Non-Alcoholic Fatty Liver Disease: Exploratory data from the Turin cohort. (March 2023)
- Main Title:
- Magnetic Resonance-based fibrosis markers in patients with Non-Alcoholic Fatty Liver Disease: Exploratory data from the Turin cohort
- Authors:
- D'Amato, D.
Tore, D.
Rosso, C.
Armandi, A.
Castelnuovo, G.
Abdulle, A.
Gjni, K.
Diaz del Campo, N. Perez
Guariglia, M.
Caviglia, G.P.
Gatti, M.
Bugianesi, E. - Abstract:
- Abstract : Introduction: In the setting of non-alcoholic fatty liver disease(NAFLD), liver fibrosis(LF) is the most relevant prognostic factor. Several non-invasive tests have been proposed to assess LF; among them, Magnetic resonance elastography(MRE) is so far the most accurate. Compared to the traditional magnetic resonance(MR), MRE requires an additional hardware with increasing procedure costs, with limited application in clinical practice. Quantitative T1-MR imaging is an emerging tool for the evaluation of LF, but its potential use has not yet been fully investigated. Aim: We aimed to explore the correlations between T1 measured on vendor specific(vendor-T1) and LivermultiScan MOLLI(LMS-T1) sequences, with MRE and vibration controlled transient elastography(VCTE) parameters, in a cohort of NAFLD patients. Methods: Between June 2021 and October 2022, we prospectively enrolled 24 NAFLD patients who underwent concomitant MR and VCTE. We extracted the following MR data(Philips Achieva 1, 5T): from MRE, stiffness measured on FFE and EPI sequences; from multiparametric liver MR, T1 with vendor specific and LMS sequences, T2, proton-density-fat-fraction(PDFF); from VCTE(Fibroscan, Echosense), stiffness and controlled attenuation parameter(CAP). Results: Median age was 54 years(interquartile range[IQR], 45-63) and 52% of the cases were males. Median liver stiffness value by VCTE was 5.9 kPa(IQR 4.4-8.4), while median CAP value was 313 dB/m(IQR 290-334). MRE-EPI stiffnessAbstract : Introduction: In the setting of non-alcoholic fatty liver disease(NAFLD), liver fibrosis(LF) is the most relevant prognostic factor. Several non-invasive tests have been proposed to assess LF; among them, Magnetic resonance elastography(MRE) is so far the most accurate. Compared to the traditional magnetic resonance(MR), MRE requires an additional hardware with increasing procedure costs, with limited application in clinical practice. Quantitative T1-MR imaging is an emerging tool for the evaluation of LF, but its potential use has not yet been fully investigated. Aim: We aimed to explore the correlations between T1 measured on vendor specific(vendor-T1) and LivermultiScan MOLLI(LMS-T1) sequences, with MRE and vibration controlled transient elastography(VCTE) parameters, in a cohort of NAFLD patients. Methods: Between June 2021 and October 2022, we prospectively enrolled 24 NAFLD patients who underwent concomitant MR and VCTE. We extracted the following MR data(Philips Achieva 1, 5T): from MRE, stiffness measured on FFE and EPI sequences; from multiparametric liver MR, T1 with vendor specific and LMS sequences, T2, proton-density-fat-fraction(PDFF); from VCTE(Fibroscan, Echosense), stiffness and controlled attenuation parameter(CAP). Results: Median age was 54 years(interquartile range[IQR], 45-63) and 52% of the cases were males. Median liver stiffness value by VCTE was 5.9 kPa(IQR 4.4-8.4), while median CAP value was 313 dB/m(IQR 290-334). MRE-EPI stiffness showed significant correlation with MRE-FFE stiffness(r= 0.84, p<0.001), VCTE stiffness(r= 0.71, p<0.001), T1(r= 0.61, p<0.005) and T2(r= 0.42, p<0.05). LMS-T1 correlated to MRE-FFE stiffness(r=0.537, p < 0.02), while T1 correlated to MRE-EPI stiffness(r=0.616, p< 0.005). At multivariate regression analysis adjusted for T2 and PDFF, both vendor-T1 and LMS-T1 were significantly and independently associated with MRE-EPI stiffness(t=3.64, p=0.002 and t=2.4, p=0.027, respectively). Conclusions: In NAFLD patients, T1 sequences may be used for the non-invasive assessment of LF. Further data from larger cohorts are needed to assess its potential use in clinical practice. Supporting grants: Italian MIUR"Dipartimenti di Eccellenza 2018-2022"D15D18000410001 and Horizon2020, no.777377, LITMUS. … (more)
- Is Part Of:
- Digestive and liver disease. Volume 55(2023)Supplement 1
- Journal:
- Digestive and liver disease
- Issue:
- Volume 55(2023)Supplement 1
- Issue Display:
- Volume 55, Issue 1 (2023)
- Year:
- 2023
- Volume:
- 55
- Issue:
- 1
- Issue Sort Value:
- 2023-0055-0001-0000
- Page Start:
- S22
- Page End:
- Publication Date:
- 2023-03
- Subjects:
- Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
616.33005 - Journal URLs:
- http://www.sciencedirect.com/science/journal/15908658 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.dld.2023.01.039 ↗
- Languages:
- English
- ISSNs:
- 1590-8658
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3588.345600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26388.xml